Sustainable responses in metastatic melanoma patients with and without brain metastases after elective discontinuation of anti-PD1-based immunotherapy due to complete response.
Dimitriou F, Zaremba A, Allayous C, Kähler KC, Gerard CL, Festino L, Schäfer S, Toussaint F, Heinzerling L, Hassel JC, Ascierto PA, Michielin O, Hauschild A, Lebbe C, Livingstone E, Ramelyte E, Cheng PF, Dummer R, Mangana J.
Dimitriou F, et al. Among authors: toussaint f.
Eur J Cancer. 2021 May;149:37-48. doi: 10.1016/j.ejca.2021.02.037. Epub 2021 Apr 3.
Eur J Cancer. 2021.
PMID: 33823361
Free article.